基于全国数据库的540623例初次全髋关节置换术后十年医疗并发症趋势
研究利用2005至2014年英格兰和威尔士医院统计数据分析540623例初次全髋关节置换术后的医疗并发症趋势。90天住院死亡率从2005年的0.60%降至2014年的0.15%,但下呼吸道感染和肾功能衰竭的30天发生率分别从0.54%升至0.84%和从0.21%升至1.09%。作者认为术后管理应聚焦于降低下呼吸道感染和肾功能衰竭风险。
要点
- 90天住院死亡率从2005年的0.60%降至2014年的0.15%。
- 下呼吸道感染30天发生率从0.54%升至0.84%,肾功能衰竭从0.21%升至1.09%。
- 下呼吸道感染(OR=42.3)和肾功能衰竭(OR=36.5)与死亡风险强烈相关。
核心结论
- 尽管人群合并症水平上升,2005至2014年质量指标改善,但下呼吸道感染和肾功能衰竭发生率例外。
- 术后管理应聚焦于降低下呼吸道感染和肾功能衰竭风险,两者均上升且与死亡强烈相关。
- 下呼吸道感染和肾功能衰竭似乎发生在可识别的高危人群中,应考虑对这些患者的常规管理进行修改。
研究设计与样本
- 利用2005至2014年医院统计数据进行的一项基于全国数据库的分析,共纳入540623例初次全髋关节置换术。
- 主要分析估计90天住院死亡率;次要分析探讨30天下呼吸道感染、肾功能衰竭、心肌梗死、肺栓塞、深静脉血栓、脑血管意外和艰难梭菌感染的发生率。
- 采用分层逻辑回归估计人群平均值,并校正时间和预后协变量。
- 证据等级为治疗性IV级。
主要发现
- 2005年1月至2014年7月共报告540623例全髋关节置换术。
- 90天死亡率从2005年的0.60%稳步下降至2014年的0.15%。
- 术后并发症(下呼吸道感染和肾功能衰竭除外)逐年减少,尽管平均Charlson合并症指数评分稳步上升。
- 下呼吸道感染30天发生率从0.54%升至0.84%,肾功能衰竭从0.21%升至1.09%。
- 下呼吸道感染患者死亡风险OR=42.3,肾功能衰竭患者OR=36.5,均高于肺栓塞(OR=10.9)或深静脉血栓(OR=2.6)患者。
关键数值与推荐
- 90天住院死亡率:2005年0.60%,2014年0.15%。
- 30天下呼吸道感染发生率从0.54%升至0.84%。
- 30天肾功能衰竭发生率从0.21%升至1.09%。
- 死亡风险:下呼吸道感染OR=42.3,肾功能衰竭OR=36.5,肺栓塞OR=10.9,深静脉血栓OR=2.6。
临床怎么用
- 作者认为术后管理应聚焦于降低下呼吸道感染和肾功能衰竭风险,两者均上升且与死亡强烈相关。
- 作者认为下呼吸道感染和肾功能衰竭似乎发生在可识别的高危人群中,应考虑对这些患者的常规管理进行修改。
- 原文未据此给出其他具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: More than 75,000 total hip replacements were performed in England and Wales in 2014, and this figure is predicted to increase. Trends in mortality and complications following total hip replacement from 2005 to 2014 were evaluated to quantify risk and to identify "at-risk" groups to better inform recommendations for patient care. METHODS: Our primary analysis estimated 90-day inpatient mortality following total hip replacement using Hospital Episode Statistics data from 2005 to 2014. Secondary analyses explored 30-day rates of lower respiratory tract infection, renal failure, myocardial infarction, pulmonary embolism, deep-vein thrombosis, cerebrovascular accident, and Clostridium difficile. Hierarchical logistic regression was used to estimate population averages, adjusting for time and prognostic covariates. RESULTS: From January 2005 to July 2014, a total of 540,623 total hip replacements were reported. The 90-day mortality rate dropped steadily, from 0.60% in 2005 to 0.15% in 2014. Reported postoperative complications (with the exception of lower respiratory tract infection and renal failure) reduced year-on-year, despite a steady rise in the average Charlson Comorbidity Index score. The 30-day rate of lower respiratory tract infection and renal failure increased from 0.54% to 0.84% and 0.21% to 1.09%, respectively. The risk of mortality was significantly higher for those who developed a lower respiratory tract infection (odds ratio [OR] = 42.3) or renal failure (OR = 36.5) than for those who developed pulmonary embolism (OR = 10.9) or deep-vein thrombosis (OR = 2.6). CONCLUSIONS: Despite a population with increasing levels of comorbidity, indicators of quality of care improved from 2005 to 2014, with the exception of the rates of lower respiratory tract infection and renal failure. Postoperative care should focus on reducing the risk of lower respiratory tract infection and renal failure, both of which increased and were strongly associated with mortality. Moreover, they appeared to occur in identifiable high-risk groups; modifications to routine care should be considered for these patients. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Partridge T, Jameson S, Baker P, et al. Ten-Year Trends in Medical Complications Following 540,623 Primary Total Hip Replacements from a National Database. J Bone Joint Surg Am. 2018. PMID: 29509612. doi:10.2106/JBJS.16.01198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。